| Rank |
Title |
Journal |
Year |
PubWeight™‹?› |
|
1
|
A randomized trial of therapies for type 2 diabetes and coronary artery disease.
|
N Engl J Med
|
2009
|
12.15
|
|
2
|
ACC/AHA/HRS 2008 Guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the ACC/AHA/NASPE 2002 Guideline Update for Implantation of Cardiac Pacemakers and Antiarrhythmia Devices): developed in collaboration with the American Association for Thoracic Surgery and Society of Thoracic Surgeons.
|
Circulation
|
2008
|
8.94
|
|
3
|
Criteria for evaluation of novel markers of cardiovascular risk: a scientific statement from the American Heart Association.
|
Circulation
|
2009
|
8.11
|
|
4
|
2010 ACCF/AHA guideline for assessment of cardiovascular risk in asymptomatic adults: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines.
|
J Am Coll Cardiol
|
2010
|
7.54
|
|
5
|
Cost-effectiveness of implantable cardioverter-defibrillators.
|
N Engl J Med
|
2005
|
7.46
|
|
6
|
Depressive symptoms and health-related quality of life: the Heart and Soul Study.
|
JAMA
|
2003
|
7.01
|
|
7
|
ACC/AHA/HRS 2008 Guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the ACC/AHA/NASPE 2002 Guideline Update for Implantation of Cardiac Pacemakers and Antiarrhythmia Devices) developed in collaboration with the American Association for Thoracic Surgery and Society of Thoracic Surgeons.
|
J Am Coll Cardiol
|
2008
|
6.78
|
|
8
|
ACCF/AHA 2009 expert consensus document on pulmonary hypertension: a report of the American College of Cardiology Foundation Task Force on Expert Consensus Documents and the American Heart Association: developed in collaboration with the American College of Chest Physicians, American Thoracic Society, Inc., and the Pulmonary Hypertension Association.
|
Circulation
|
2009
|
5.49
|
|
9
|
ACCF/AHA 2007 clinical expert consensus document on coronary artery calcium scoring by computed tomography in global cardiovascular risk assessment and in evaluation of patients with chest pain: a report of the American College of Cardiology Foundation Clinical Expert Consensus Task Force (ACCF/AHA Writing Committee to Update the 2000 Expert Consensus Document on Electron Beam Computed Tomography).
|
Circulation
|
2007
|
4.66
|
|
10
|
2010 ACCF/AHA guideline for assessment of cardiovascular risk in asymptomatic adults: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines.
|
Circulation
|
2010
|
4.56
|
|
11
|
ACC/AHA/NASPE 2002 guideline update for implantation of cardiac pacemakers and antiarrhythmia devices: summary article: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/NASPE Committee to Update the 1998 Pacemaker Guidelines).
|
Circulation
|
2002
|
3.89
|
|
12
|
Cost-effectiveness of preparticipation screening for prevention of sudden cardiac death in young athletes.
|
Ann Intern Med
|
2010
|
3.45
|
|
13
|
2012 ACCF/AHA/HRS focused update incorporated into the ACCF/AHA/HRS 2008 guidelines for device-based therapy of cardiac rhythm abnormalities: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines and the Heart Rhythm Society.
|
J Am Coll Cardiol
|
2012
|
3.25
|
|
14
|
Association of coronary CT angiography or stress testing with subsequent utilization and spending among Medicare beneficiaries.
|
JAMA
|
2011
|
3.17
|
|
15
|
Systematic review: the comparative effectiveness of percutaneous coronary interventions and coronary artery bypass graft surgery.
|
Ann Intern Med
|
2007
|
3.10
|
|
16
|
Cardiac resynchronization therapy for patients with left ventricular systolic dysfunction: a systematic review.
|
JAMA
|
2007
|
2.93
|
|
17
|
ACC/AHA/HRS 2008 guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities: executive summary.
|
Heart Rhythm
|
2008
|
2.75
|
|
18
|
Integrating complementary medicine into cardiovascular medicine. A report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents (Writing Committee to Develop an Expert Consensus Document on Complementary and Integrative Medicine).
|
J Am Coll Cardiol
|
2005
|
2.71
|
|
19
|
Susceptibility locus for clinical and subclinical coronary artery disease at chromosome 9p21 in the multi-ethnic ADVANCE study.
|
Hum Mol Genet
|
2008
|
2.71
|
|
20
|
Cost-effectiveness of genotype-guided and dual antiplatelet therapies in acute coronary syndrome.
|
Ann Intern Med
|
2014
|
2.69
|
|
21
|
ACCF/ACG/AHA 2008 expert consensus document on reducing the gastrointestinal risks of antiplatelet therapy and NSAID use: a report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents.
|
J Am Coll Cardiol
|
2008
|
2.67
|
|
22
|
Patient management after noninvasive cardiac imaging results from SPARC (Study of myocardial perfusion and coronary anatomy imaging roles in coronary artery disease).
|
J Am Coll Cardiol
|
2012
|
2.60
|
|
23
|
2010 ACCF/AHA guideline for assessment of cardiovascular risk in asymptomatic adults: executive summary: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines.
|
Circulation
|
2010
|
2.58
|
|
24
|
Impact of the Screening Abdominal Aortic Aneurysms Very Efficiently (SAAAVE) Act on abdominal ultrasonography use among Medicare beneficiaries.
|
Arch Intern Med
|
2012
|
2.57
|
|
25
|
2012 ACCF/AHA/HRS focused update incorporated into the ACCF/AHA/HRS 2008 guidelines for device-based therapy of cardiac rhythm abnormalities: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines and the Heart Rhythm Society.
|
Circulation
|
2012
|
2.39
|
|
26
|
Validation of a new brief physical activity survey among men and women aged 60-69 years.
|
Am J Epidemiol
|
2006
|
2.37
|
|
27
|
Cost-effectiveness of coronary artery bypass grafts versus percutaneous coronary intervention for revascularization of high-risk patients.
|
Circulation
|
2006
|
2.24
|
|
28
|
Lack of association between the Trp719Arg polymorphism in kinesin-like protein-6 and coronary artery disease in 19 case-control studies.
|
J Am Coll Cardiol
|
2010
|
2.17
|
|
29
|
Differences in medical care and disease outcomes among black and white women with heart disease.
|
Circulation
|
2003
|
2.16
|
|
30
|
ACC/AHA/NASPE 2002 guideline update for implantation of cardiac pacemakers and antiarrhythmia devices: summary article. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/NASPE Committee to Update the 1998 Pacemaker Guidelines).
|
J Cardiovasc Electrophysiol
|
2002
|
2.14
|
|
31
|
Cost-effectiveness of percutaneous coronary intervention in patients with stable coronary artery disease and abnormal fractional flow reserve.
|
Circulation
|
2013
|
2.13
|
|
32
|
Procedural complications, rehospitalizations, and repeat procedures after catheter ablation for atrial fibrillation.
|
J Am Coll Cardiol
|
2012
|
2.05
|
|
33
|
Characterizing the admixed African ancestry of African Americans.
|
Genome Biol
|
2009
|
2.01
|
|
34
|
Cost-effectiveness of using high-sensitivity C-reactive protein to identify intermediate- and low-cardiovascular-risk individuals for statin therapy.
|
Circulation
|
2010
|
2.00
|
|
35
|
ACC/AHA/NASPE 2002 Guideline Update for Implantation of Cardiac Pacemakers and Antiarrhythmia Devices--summary article: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/NASPE Committee to Update the 1998 Pacemaker Guidelines).
|
J Am Coll Cardiol
|
2002
|
1.94
|
|
36
|
ACC/AHA Clinical Performance Measures for Adults with Chronic Heart Failure: a report of the American College of Cardiology/American Heart Association Task Force on Performance Measures (Writing Committee to Develop Heart Failure Clinical Performance Measures): endorsed by the Heart Failure Society of America.
|
Circulation
|
2005
|
1.90
|
|
37
|
The relation between hospital procedure volume and complications of cardioverter-defibrillator implantation from the implantable cardioverter-defibrillator registry.
|
J Am Coll Cardiol
|
2010
|
1.87
|
|
38
|
ACC/AHA clinical performance measures for adults with chronic heart failure: a report of the American College of Cardiology/American Heart Association Task Force on Performance Measures (Writing Committee to Develop Heart Failure Clinical Performance Measures) endorsed by the Heart Failure Society of America.
|
J Am Coll Cardiol
|
2005
|
1.76
|
|
39
|
Statin and beta-blocker therapy and the initial presentation of coronary heart disease.
|
Ann Intern Med
|
2006
|
1.72
|
|
40
|
ACC/AHA/HRS 2008 Guidelines for device-based therapy of cardiac rhythm abnormalities.
|
Heart Rhythm
|
2008
|
1.72
|
|
41
|
Effectiveness and safety of digoxin among contemporary adults with incident systolic heart failure.
|
Circ Cardiovasc Qual Outcomes
|
2013
|
1.71
|
|
42
|
Transcatheter aortic valve replacement in nonsurgical candidates with severe, symptomatic aortic stenosis: a cost-effectiveness analysis.
|
Circ Cardiovasc Qual Outcomes
|
2013
|
1.68
|
|
43
|
Isolated disease of the proximal left anterior descending artery comparing the effectiveness of percutaneous coronary interventions and coronary artery bypass surgery.
|
JACC Cardiovasc Interv
|
2008
|
1.66
|
|
44
|
Cost-effectiveness of bypass surgery versus stenting in patients with multivessel coronary artery disease.
|
Am J Med
|
2003
|
1.63
|
|
45
|
ACCF/ACR/AHA/NASCI/SAIP/SCAI/SCCT 2010 expert consensus document on coronary computed tomographic angiography: a report of the American College of Cardiology Foundation Task Force on Expert Consensus Documents.
|
J Am Coll Cardiol
|
2010
|
1.63
|
|
46
|
ACC/AHA statement on cost/value methodology in clinical practice guidelines and performance measures: a report of the American College of Cardiology/American Heart Association Task Force on Performance Measures and Task Force on Practice Guidelines.
|
J Am Coll Cardiol
|
2014
|
1.58
|
|
47
|
Health status after treatment for coronary artery disease and type 2 diabetes mellitus in the Bypass Angioplasty Revascularization Investigation 2 Diabetes trial.
|
Circulation
|
2010
|
1.56
|
|
48
|
The effect of age on outcomes of coronary artery bypass surgery compared with balloon angioplasty or bare-metal stent implantation among patients with multivessel coronary disease. A collaborative analysis of individual patient data from 10 randomized trials.
|
J Am Coll Cardiol
|
2012
|
1.46
|
|
49
|
Cost-effectiveness of a conservative, ischemia-guided management strategy after non-Q-wave myocardial infarction: results of a randomized trial.
|
Circulation
|
2002
|
1.46
|
|
50
|
Strengthening the reporting of Genetic RIsk Prediction Studies (GRIPS): explanation and elaboration.
|
J Clin Epidemiol
|
2011
|
1.46
|
|
51
|
2012 ACCF/AHA/HRS focused update of the 2008 guidelines for device-based therapy of cardiac rhythm abnormalities: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines.
|
J Thorac Cardiovasc Surg
|
2012
|
1.45
|
|
52
|
ACCF/ACR/AHA/NASCI/SAIP/SCAI/SCCT 2010 expert consensus document on coronary computed tomographic angiography: a report of the American College of Cardiology Foundation Task Force on Expert Consensus Documents.
|
Circulation
|
2010
|
1.45
|
|
53
|
Multivessel coronary artery bypass grafting versus percutaneous coronary intervention in ESRD.
|
J Am Soc Nephrol
|
2012
|
1.42
|
|
54
|
Effectiveness and cost-effectiveness of implantable cardioverter defibrillators in the treatment of ventricular arrhythmias among medicare beneficiaries.
|
Am J Med
|
2002
|
1.41
|
|
55
|
Repeat coronary revascularization procedures after successful bare-metal or drug-eluting stent implantation.
|
J Invasive Cardiol
|
2010
|
1.40
|
|
56
|
Metabolic syndrome and early-onset coronary artery disease: is the whole greater than its parts?
|
J Am Coll Cardiol
|
2006
|
1.40
|
|
57
|
Cost-Effectiveness of Adding Cardiac Resynchronization Therapy to an Implantable Cardioverter-Defibrillator Among Patients With Mild Heart Failure.
|
Ann Intern Med
|
2015
|
1.39
|
|
58
|
Health-related quality of life in patients with pulmonary arterial hypertension.
|
Chest
|
2004
|
1.34
|
|
59
|
ACCF/ACG/AHA 2010 expert consensus document on the concomitant use of proton pump inhibitors and thienopyridines: a focused update of the ACCF/ACG/AHA 2008 expert consensus document on reducing the gastrointestinal risks of antiplatelet therapy and NSAID use. A Report of the American College of Cardiology Foundation Task Force on Expert Consensus Documents.
|
J Am Coll Cardiol
|
2010
|
1.31
|
|
60
|
Insulin resistance independently predicts the progression of coronary artery calcification.
|
Am Heart J
|
2009
|
1.26
|
|
61
|
ACCF/ACG/AHA 2010 expert consensus document on the concomitant use of proton pump inhibitors and thienopyridines: a focused update of the ACCF/ACG/AHA 2008 expert consensus document on reducing the gastrointestinal risks of antiplatelet therapy and NSAID use.
|
Am J Gastroenterol
|
2010
|
1.24
|
|
62
|
Expanding the orbit of primary prevention--moving beyond JUPITER.
|
N Engl J Med
|
2008
|
1.24
|
|
63
|
ACCF/ACG/AHA 2008 expert consensus document on reducing the gastrointestinal risks of antiplatelet therapy and NSAID use.
|
Am J Gastroenterol
|
2008
|
1.21
|
|
64
|
Medical economics and the assessment of value in cardiovascular medicine: Part I.
|
Circulation
|
2002
|
1.16
|
|
65
|
Clinical utility of the Stanford brief activity survey in men and women with early-onset coronary artery disease.
|
J Cardiopulm Rehabil Prev
|
2007
|
1.15
|
|
66
|
Rheumatoid arthritis and cardiovascular disease.
|
Am Heart J
|
2013
|
1.14
|
|
67
|
ACCF/ACG/AHA 2010 Expert Consensus Document on the concomitant use of proton pump inhibitors and thienopyridines: a focused update of the ACCF/ACG/AHA 2008 expert consensus document on reducing the gastrointestinal risks of antiplatelet therapy and NSAID use: a report of the American College of Cardiology Foundation Task Force on Expert Consensus Documents.
|
Circulation
|
2010
|
1.12
|
|
68
|
Conducting economic evaluations alongside multinational clinical trials: toward a research consensus.
|
Am Heart J
|
2005
|
1.12
|
|
69
|
Incidental findings on cardiac multidetector row computed tomography among healthy older adults: prevalence and clinical correlates.
|
Arch Intern Med
|
2008
|
1.12
|
|
70
|
ACC/AHA statement on cost/value methodology in clinical practice guidelines and performance measures: a report of the American College of Cardiology/American Heart Association Task Force on Performance Measures and Task Force on Practice Guidelines.
|
Circulation
|
2014
|
1.12
|
|
71
|
The study of myocardial perfusion and coronary anatomy imaging roles in CAD (SPARC): design, rationale, and baseline patient characteristics of a prospective, multicenter observational registry comparing PET, SPECT, and CTA for resource utilization and clinical outcomes.
|
J Nucl Cardiol
|
2009
|
1.12
|
|
72
|
Cost effectiveness of cardiac resynchronization therapy.
|
J Am Coll Cardiol
|
2005
|
1.10
|
|
73
|
ACCF/AHA 2011 expert consensus document on hypertension in the elderly: a report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents developed in collaboration with the American Academy of Neurology, American Geriatrics Society, American Society for Preventive Cardiology, American Society of Hypertension, American Society of Nephrology, Association of Black Cardiologists, and European Society of Hypertension.
|
J Am Soc Hypertens
|
2011
|
1.09
|
|
74
|
Validation of the Stanford Brief Activity Survey: examining psychological factors and physical activity levels in older adults.
|
J Phys Act Health
|
2010
|
1.06
|
|
75
|
Underuse of evidence-based therapies.
|
Circulation
|
2004
|
1.06
|
|
76
|
Quality of life and time trade-off utility measures in patients with coronary artery disease.
|
Am Heart J
|
2003
|
1.05
|
|
77
|
Association of polymorphisms in platelet and hemostasis system genes with acute myocardial infarction.
|
Am Heart J
|
2007
|
1.05
|
|
78
|
Association between the chromosome 9p21 locus and angiographic coronary artery disease burden: a collaborative meta-analysis.
|
J Am Coll Cardiol
|
2013
|
1.02
|
|
79
|
A near null variant of 12/15-LOX encoded by a novel SNP in ALOX15 and the risk of coronary artery disease.
|
Atherosclerosis
|
2007
|
1.01
|
|
80
|
Women's Ischemic Syndrome Evaluation: current status and future research directions: report of the National Heart, Lung and Blood Institute workshop: October 2-4, 2002: Section 5: gender-related risk factors for ischemic heart disease.
|
Circulation
|
2004
|
1.00
|
|
81
|
Trends in the incidence of atrial fibrillation in older patients initiating dialysis in the United States.
|
Circulation
|
2012
|
0.99
|
|
82
|
Incidental pulmonary nodules on cardiac computed tomography: prognosis and use.
|
Am J Med
|
2008
|
0.98
|
|
83
|
Physical and sexual function in women with chronic kidney disease.
|
Am J Kidney Dis
|
2004
|
0.98
|
|
84
|
American Heart Association atrial fibrillation research summit: a conference report from the American Heart Association.
|
Circulation
|
2011
|
0.97
|
|
85
|
ACC/AHA/ASE/ASNC/HRS/IAC/Mended Hearts/NASCI/RSNA/SAIP/SCAI/SCCT/SCMR/SNMMI 2014 health policy statement on use of noninvasive cardiovascular imaging: a report of the American College of Cardiology Clinical Quality Committee.
|
J Am Coll Cardiol
|
2014
|
0.96
|
|
86
|
Ethnic differences in coronary artery calcium in a healthy cohort aged 60 to 69 years.
|
Am J Cardiol
|
2007
|
0.96
|
|
87
|
Physician procedure volume and complications of cardioverter-defibrillator implantation.
|
Circulation
|
2011
|
0.95
|
|
88
|
Strengthening the reporting of genetic risk prediction studies (GRIPS): explanation and elaboration.
|
Eur J Epidemiol
|
2011
|
0.94
|
|
89
|
Framework for evaluating novel risk markers.
|
Ann Intern Med
|
2012
|
0.93
|
|
90
|
Surgery for Aortic Dilatation in Patients With Bicuspid Aortic Valves: A Statement of Clarification From the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines.
|
Circulation
|
2015
|
0.93
|
|
91
|
ACCF/ACR/AHA/NASCI/SAIP/SCAI/SCCT 2010 expert consensus document on coronary computed tomographic angiography: a report of the American College of Cardiology Foundation Task Force on Expert Consensus Documents.
|
Catheter Cardiovasc Interv
|
2010
|
0.92
|
|
92
|
Distribution of asymmetric dimethylarginine among 980 healthy, older adults of different ethnicities.
|
Clin Chem
|
2009
|
0.91
|
|
93
|
Effect of risk stratification on cost-effectiveness of the implantable cardioverter defibrillator.
|
Am Heart J
|
2002
|
0.91
|
|
94
|
Cost-effectiveness of genetic testing in family members of patients with long-QT syndrome.
|
Circ Cardiovasc Qual Outcomes
|
2010
|
0.90
|
|
95
|
Synthesizing lessons learned from get with the guidelines: the value of disease-based registries in improving quality and outcomes.
|
Circulation
|
2013
|
0.90
|
|
96
|
2016 ACC/AHA guideline focused update on duration of dual antiplatelet therapy in patients with coronary artery disease: A report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines.
|
J Thorac Cardiovasc Surg
|
2016
|
0.89
|
|
97
|
Self-rated health among women with coronary disease: depression is as important as recent cardiovascular events.
|
Am Heart J
|
2006
|
0.88
|
|
98
|
Medical economics and the assessment of value in cardiovascular medicine: Part II.
|
Circulation
|
2002
|
0.88
|
|
99
|
The dilemma of incidental findings on cardiac computed tomography.
|
J Am Coll Cardiol
|
2009
|
0.87
|
|
100
|
A systematic review of the economic burden of chronic angina.
|
Am J Manag Care
|
2004
|
0.87
|
|
101
|
Chronic kidney disease and risk for presenting with acute myocardial infarction versus stable exertional angina in adults with coronary heart disease.
|
J Am Coll Cardiol
|
2011
|
0.86
|
|
102
|
Plasma leptin levels and coronary artery calcification in older adults.
|
J Clin Endocrinol Metab
|
2006
|
0.86
|
|
103
|
Peroxisome proliferator-activated receptor gamma polymorphisms and coronary heart disease.
|
PPAR Res
|
2009
|
0.86
|
|
104
|
Management of ventricular arrhythmias in diverse populations in California.
|
Am Heart J
|
2002
|
0.85
|
|
105
|
Strengthening the reporting of genetic risk prediction studies (GRIPS): explanation and elaboration.
|
Eur J Clin Invest
|
2011
|
0.85
|
|
106
|
Risk of sudden versus nonsudden cardiac death in patients with coronary artery disease.
|
Am Heart J
|
2002
|
0.85
|
|
107
|
Persistent racial disparities in survival after heart transplantation.
|
Circulation
|
2011
|
0.84
|
|
108
|
The effect of bivalirudin on costs and outcomes of treatment of ST-segment elevation myocardial infarction.
|
Am Heart J
|
2011
|
0.83
|
|
109
|
Effectiveness is the key to cost-effectiveness.
|
Circulation
|
2013
|
0.83
|
|
110
|
Health-related quality of life following coronary artery bypass graft surgery in post-menopausal women.
|
J Gen Intern Med
|
2008
|
0.83
|
|
111
|
Compelling evidence for coronary-bypass surgery in patients with diabetes.
|
N Engl J Med
|
2012
|
0.83
|
|
112
|
Right coronary wall CMR in the older asymptomatic advance cohort: positive remodeling and associations with type 2 diabetes and coronary calcium.
|
J Cardiovasc Magn Reson
|
2010
|
0.83
|
|
113
|
Cost analysis of non-invasive fractional flow reserve derived from coronary computed tomographic angiography in Japan.
|
Cardiovasc Interv Ther
|
2014
|
0.82
|
|
114
|
Comorbidity and outcome in patients with coronary artery disease.
|
J Am Coll Cardiol
|
2004
|
0.82
|
|
115
|
2015 ACC/AHA/SCAI focused update on primary percutaneous coronary intervention for patients with ST-elevation myocardial Infarction: An update of the 2011 ACCF/AHA/SCAI guideline for percutaneous coronary intervention and the 2013 ACCF/AHA guideline for the management of ST-elevation myocardial infarction: A report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Society for Cardiovascular Angiography and Interventions.
|
Catheter Cardiovasc Interv
|
2016
|
0.82
|
|
116
|
Potential role of differential medication use in explaining excess risk of cardiovascular events and death associated with chronic kidney disease: a cohort study.
|
BMC Nephrol
|
2011
|
0.82
|
|
117
|
Effect of race on the clinical outcomes in the bypass angioplasty revascularization investigation trial.
|
Circ Cardiovasc Qual Outcomes
|
2009
|
0.81
|
|
118
|
Comparative effectiveness of coronary artery bypass grafting and percutaneous coronary intervention for multivessel coronary disease in a community-based population with chronic kidney disease.
|
Am Heart J
|
2013
|
0.81
|
|
119
|
Ankle brachial index screening in asymptomatic older adults.
|
Am Heart J
|
2011
|
0.80
|
|
120
|
Preventing tomorrow's sudden cardiac death today: part II: Translating sudden cardiac death risk assessment strategies into practice and policy.
|
Am Heart J
|
2007
|
0.80
|
|
121
|
Cross-cultural adaptation and assessment of reproducibility of the Duke Activity Status Index for COPD patients in Brazil.
|
J Bras Pneumol
|
2013
|
0.80
|
|
122
|
Repeat revascularization is a faulty end point for clinical trials.
|
Circ Cardiovasc Qual Outcomes
|
2012
|
0.80
|
|
123
|
Effectiveness and safety of spironolactone for systolic heart failure.
|
Am J Cardiol
|
2013
|
0.80
|
|
124
|
Strengthening the reporting of genetic risk prediction studies (GRIPS): explanation and elaboration.
|
Eur J Hum Genet
|
2011
|
0.79
|
|
125
|
Overview of randomized trials of antiarrhythmic drugs and devices for the prevention of sudden cardiac death.
|
Am Heart J
|
2002
|
0.79
|
|
126
|
Racial variation in lipoprotein-associated phospholipase A₂ in older adults.
|
BMC Cardiovasc Disord
|
2011
|
0.79
|
|
127
|
Improvement in quality of life after radiofrequency ablation.
|
Pacing Clin Electrophysiol
|
2006
|
0.79
|
|
128
|
Life after a ventricular arrhythmia.
|
Am Heart J
|
2002
|
0.79
|
|
129
|
Do plasma biomarkers of coagulation and fibrinolysis differ between patients who have experienced an acute myocardial infarction versus stable exertional angina?
|
Am Heart J
|
2007
|
0.78
|
|
130
|
Body mass index and health status in the Bypass Angioplasty Revascularization Investigation 2 Diabetes Trial (BARI 2D).
|
Am Heart J
|
2011
|
0.78
|
|
131
|
Facility factors dominate the ability to achieve target haemoglobin levels in haemodialysis patients.
|
Nephrol Dial Transplant
|
2008
|
0.78
|
|
132
|
Coronary revascularization and quality of life.
|
Am Heart J
|
2004
|
0.78
|
|
133
|
Trends in hospital treatment of ventricular arrhythmias among Medicare beneficiaries, 1985 to 1995.
|
Am Heart J
|
2002
|
0.77
|
|
134
|
Does practice variation matter?
|
J Am Coll Cardiol
|
2013
|
0.77
|
|
135
|
Cardiac resynchronization for heart failure.
|
Ann Intern Med
|
2004
|
0.76
|
|
136
|
Evaluating use of coronary computed tomography angiography in the emergency department.
|
J Am Coll Cardiol
|
2009
|
0.76
|
|
137
|
2017 ACC/AHA/HFSA Focused Update of the 2013 ACCF/AHA Guideline for the Management of Heart Failure: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Failure Society of America.
|
J Card Fail
|
2017
|
0.75
|
|
138
|
Physical activity in older subjects is associated with increased coronary vasodilation: the ADVANCE study.
|
JACC Cardiovasc Imaging
|
2011
|
0.75
|
|
139
|
ACP Journal Club. Reynolds Risk Score for men predicted cardiovascular events more accurately than traditional risk factors only.
|
Ann Intern Med
|
2009
|
0.75
|
|
140
|
The effect of age on clinical outcomes and health status BARI 2D (Bypass Angioplasty Revascularization Investigation in Type 2 Diabetes).
|
J Am Coll Cardiol
|
2011
|
0.75
|
|
141
|
Reply: Beta-blockers for angina: time to reassess the specific impact of drug therapy in coronary heart disease patients.
|
J Am Coll Cardiol
|
2014
|
0.75
|
|
142
|
Cost-effectiveness of genotype-guided and dual antiplatelet therapies. In response.
|
Ann Intern Med
|
2014
|
0.75
|
|
143
|
Comparative effectiveness of multivessel coronary artery bypass graft surgery and multivessel percutaneous coronary intervention.
|
Ann Intern Med
|
2013
|
0.75
|
|
144
|
Effectiveness of β-blockers in heart failure with left ventricular systolic dysfunction and chronic kidney disease.
|
J Card Fail
|
2013
|
0.75
|
|
145
|
Vision and creation of the American Heart Association pharmaceutical roundtable outcomes research centers.
|
Circ Cardiovasc Qual Outcomes
|
2009
|
0.75
|
|
146
|
Cardiac outcomes occurred more frequently with PCI than CABG or medical therapy in coronary artery disease.
|
ACP J Club
|
2004
|
0.75
|
|
147
|
Stents or surgery? New data on the comparative outcomes of percutaneous coronary intervention and coronary artery bypass graft surgery.
|
Circulation
|
2008
|
0.75
|
|
148
|
The confirmatory trial in comparative-effectiveness research.
|
N Engl J Med
|
2009
|
0.75
|
|
149
|
Highlights of the year in JACC 2012.
|
J Am Coll Cardiol
|
2013
|
0.75
|
|
150
|
Atrial fibrillation ablation, symptoms, and stroke risk: comment on "Discerning the incidence of symptomatic and asymptomatic episodes of atrial fibrillation before and after catheter ablation (DISCERN AF)".
|
JAMA Intern Med
|
2013
|
0.75
|
|
151
|
ACP journal club. Review: in diabetes with multivessel or left main CAD, PCI increases death/MI/stroke combo compared with CABG.
|
Ann Intern Med
|
2015
|
0.75
|
|
152
|
A risk score for predicting 30-day mortality in heart failure patients undergoing non-cardiac surgery.
|
Eur J Heart Fail
|
2014
|
0.75
|
|
153
|
ACCF/AHA/CDC conference report on emerging infectious diseases and biological terrorism threats: the clinical and public health implications for the prevention and control of cardiovascular diseases.
|
J Am Coll Cardiol
|
2007
|
0.75
|
|
154
|
Does enrollment in a randomized clinical trial lead to a higher cost of routine care?
|
Am Heart J
|
2002
|
0.75
|
|
155
|
Methodological Standards for Meta-Analyses and Qualitative Systematic Reviews of Cardiac Prevention and Treatment Studies: A Scientific Statement From the American Heart Association.
|
Circulation
|
2017
|
0.75
|
|
156
|
2016 AHA/ACC Guideline on the Management of Patients with Lower Extremity Peripheral Artery Disease: Executive Summary.
|
Vasc Med
|
2017
|
0.75
|
|
157
|
Further Evolution of the ACC/AHA Clinical Practice Guideline Recommendation Classification System: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines.
|
Circulation
|
2015
|
0.75
|
|
158
|
2017 AHA/ACC/HRS Guideline for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society.
|
Circulation
|
2017
|
0.75
|
|
159
|
Effect of postmenopausal hormone therapy on coronary heart disease events after percutaneous transluminal coronary angioplasty.
|
Am J Cardiol
|
2003
|
0.75
|
|
160
|
Late diagnosis of abdominal aortic aneurysms substantiates underutilization of abdominal aortic aneurysm screening for Medicare beneficiaries.
|
J Vasc Surg
|
2013
|
0.75
|
|
161
|
ACCF/AHA/CDC conference report on emerging infectious diseases and biological terrorism threats: the clinical and public health implications for the prevention and control of cardiovascular diseases.
|
Circulation
|
2007
|
0.75
|
|
162
|
2017 AHA/ACC/HRS Guideline for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society.
|
Circulation
|
2017
|
0.75
|
|
163
|
Further Evolution of the ACC/AHA Clinical Practice Guideline Recommendation Classification System: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines.
|
J Am Coll Cardiol
|
2015
|
0.75
|